table of content
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Tests Overall Market Size
2.1 Global Precision Cancer Tests Market Size: 2021 VS 2028
2.2 Global Precision Cancer Tests Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Tests Players in Global Market
3.2 Top Global Precision Cancer Tests Companies Ranked by Revenue
3.3 Global Precision Cancer Tests Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Tests Companies in Global Market, by Revenue in 2021
3.5 Global Companies Precision Cancer Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Tests Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Precision Cancer Tests Market Size Markets, 2021 & 2028
4.1.2 Imaging
4.1.3 In Vitro Diagnostic
4.1.4 Others
4.2 By Type - Global Precision Cancer Tests Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Tests Revenue, 2017-2022
4.2.2 By Type - Global Precision Cancer Tests Revenue, 2023-2028
4.2.3 By Type - Global Precision Cancer Tests Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Tests Market Size, 2021 & 2028
5.1.2 Cancer Research Centers
5.1.3 Cancer Hospital
5.1.4 Surgical Centers
5.1.5 Clinics
5.1.6 Others
5.2 By Application - Global Precision Cancer Tests Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Tests Revenue, 2017-2022
5.2.2 By Application - Global Precision Cancer Tests Revenue, 2023-2028
5.2.3 By Application - Global Precision Cancer Tests Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Precision Cancer Tests Market Size, 2021 & 2028
6.2 By Region - Global Precision Cancer Tests Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Tests Revenue, 2017-2022
6.2.2 By Region - Global Precision Cancer Tests Revenue, 2023-2028
6.2.3 By Region - Global Precision Cancer Tests Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Precision Cancer Tests Revenue, 2017-2028
6.3.2 US Precision Cancer Tests Market Size, 2017-2028
6.3.3 Canada Precision Cancer Tests Market Size, 2017-2028
6.3.4 Mexico Precision Cancer Tests Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Tests Revenue, 2017-2028
6.4.2 Germany Precision Cancer Tests Market Size, 2017-2028
6.4.3 France Precision Cancer Tests Market Size, 2017-2028
6.4.4 U.K. Precision Cancer Tests Market Size, 2017-2028
6.4.5 Italy Precision Cancer Tests Market Size, 2017-2028
6.4.6 Russia Precision Cancer Tests Market Size, 2017-2028
6.4.7 Nordic Countries Precision Cancer Tests Market Size, 2017-2028
6.4.8 Benelux Precision Cancer Tests Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Tests Revenue, 2017-2028
6.5.2 China Precision Cancer Tests Market Size, 2017-2028
6.5.3 Japan Precision Cancer Tests Market Size, 2017-2028
6.5.4 South Korea Precision Cancer Tests Market Size, 2017-2028
6.5.5 Southeast Asia Precision Cancer Tests Market Size, 2017-2028
6.5.6 India Precision Cancer Tests Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Precision Cancer Tests Revenue, 2017-2028
6.6.2 Brazil Precision Cancer Tests Market Size, 2017-2028
6.6.3 Argentina Precision Cancer Tests Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Tests Revenue, 2017-2028
6.7.2 Turkey Precision Cancer Tests Market Size, 2017-2028
6.7.3 Israel Precision Cancer Tests Market Size, 2017-2028
6.7.4 Saudi Arabia Precision Cancer Tests Market Size, 2017-2028
6.7.5 UAE Precision Cancer Tests Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Precision Cancer Tests Major Product Offerings
7.1.4 Abbott Precision Cancer Tests Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 BD
7.2.1 BD Corporate Summary
7.2.2 BD Business Overview
7.2.3 BD Precision Cancer Tests Major Product Offerings
7.2.4 BD Precision Cancer Tests Revenue in Global Market (2017-2022)
7.2.5 BD Key News
7.3 Bio-Rad
7.3.1 Bio-Rad Corporate Summary
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Precision Cancer Tests Major Product Offerings
7.3.4 Bio-Rad Precision Cancer Tests Revenue in Global Market (2017-2022)
7.3.5 Bio-Rad Key News
7.4 Cynvenio Biosystems
7.4.1 Cynvenio Biosystems Corporate Summary
7.4.2 Cynvenio Biosystems Business Overview
7.4.3 Cynvenio Biosystems Precision Cancer Tests Major Product Offerings
7.4.4 Cynvenio Biosystems Precision Cancer Tests Revenue in Global Market (2017-2022)
7.4.5 Cynvenio Biosystems Key News
7.5 Foundation Medicine
7.5.1 Foundation Medicine Corporate Summary
7.5.2 Foundation Medicine Business Overview
7.5.3 Foundation Medicine Precision Cancer Tests Major Product Offerings
7.5.4 Foundation Medicine Precision Cancer Tests Revenue in Global Market (2017-2022)
7.5.5 Foundation Medicine Key News
7.6 Genomic Health
7.6.1 Genomic Health Corporate Summary
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Precision Cancer Tests Major Product Offerings
7.6.4 Genomic Health Precision Cancer Tests Revenue in Global Market (2017-2022)
7.6.5 Genomic Health Key News
7.7 Illumina
7.7.1 Illumina Corporate Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Precision Cancer Tests Major Product Offerings
7.7.4 Illumina Precision Cancer Tests Revenue in Global Market (2017-2022)
7.7.5 Illumina Key News
7.8 Myriad Genetics
7.8.1 Myriad Genetics Corporate Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Precision Cancer Tests Major Product Offerings
7.8.4 Myriad Genetics Precision Cancer Tests Revenue in Global Market (2017-2022)
7.8.5 Myriad Genetics Key News
7.9 NanoString Technologies
7.9.1 NanoString Technologies Corporate Summary
7.9.2 NanoString Technologies Business Overview
7.9.3 NanoString Technologies Precision Cancer Tests Major Product Offerings
7.9.4 NanoString Technologies Precision Cancer Tests Revenue in Global Market (2017-2022)
7.9.5 NanoString Technologies Key News
7.10 QIAGEN
7.10.1 QIAGEN Corporate Summary
7.10.2 QIAGEN Business Overview
7.10.3 QIAGEN Precision Cancer Tests Major Product Offerings
7.10.4 QIAGEN Precision Cancer Tests Revenue in Global Market (2017-2022)
7.10.5 QIAGEN Key News
7.11 Randox Laboratories
7.11.1 Randox Laboratories Corporate Summary
7.11.2 Randox Laboratories Business Overview
7.11.3 Randox Laboratories Precision Cancer Tests Major Product Offerings
7.11.4 Randox Laboratories Precision Cancer Tests Revenue in Global Market (2017-2022)
7.11.5 Randox Laboratories Key News
7.12 Roche
7.12.1 Roche Corporate Summary
7.12.2 Roche Business Overview
7.12.3 Roche Precision Cancer Tests Major Product Offerings
7.12.4 Roche Precision Cancer Tests Revenue in Global Market (2017-2022)
7.12.5 Roche Key News
7.13 Philips
7.13.1 Philips Corporate Summary
7.13.2 Philips Business Overview
7.13.3 Philips Precision Cancer Tests Major Product Offerings
7.13.4 Philips Precision Cancer Tests Revenue in Global Market (2017-2022)
7.13.5 Philips Key News
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Corporate Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Precision Cancer Tests Major Product Offerings
7.14.4 Thermo Fisher Scientific Precision Cancer Tests Revenue in Global Market (2017-2022)
7.14.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
